{"title":"肿瘤坏死抗因子治疗类风湿性关节炎患者副作用发展的相关因素","authors":"Ruth López-González, Olga Martínez-González","doi":"10.1016/j.semreu.2013.04.001","DOIUrl":null,"url":null,"abstract":"<div><p>This article reviews the papers published on the factors related to the development of adverse effects in rheumatoid arthritis patients treated with anti-tumor necrosis factor-α drugs.</p><p>The adverse effects studied were: infectious disease, cardiovascular complications, tumor development and mortality risk.</p></div>","PeriodicalId":101152,"journal":{"name":"Seminarios de la Fundación Espa?ola de Reumatología","volume":"14 3","pages":"Pages 69-71"},"PeriodicalIF":0.0000,"publicationDate":"2013-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.semreu.2013.04.001","citationCount":"0","resultStr":"{\"title\":\"Factores asociados al desarrollo de efectos secundarios en pacientes con artritis reumatoide tratados con anti-factor de necrosis tumoral alfa\",\"authors\":\"Ruth López-González, Olga Martínez-González\",\"doi\":\"10.1016/j.semreu.2013.04.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>This article reviews the papers published on the factors related to the development of adverse effects in rheumatoid arthritis patients treated with anti-tumor necrosis factor-α drugs.</p><p>The adverse effects studied were: infectious disease, cardiovascular complications, tumor development and mortality risk.</p></div>\",\"PeriodicalId\":101152,\"journal\":{\"name\":\"Seminarios de la Fundación Espa?ola de Reumatología\",\"volume\":\"14 3\",\"pages\":\"Pages 69-71\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.semreu.2013.04.001\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Seminarios de la Fundación Espa?ola de Reumatología\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S157735661300033X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminarios de la Fundación Espa?ola de Reumatología","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S157735661300033X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Factores asociados al desarrollo de efectos secundarios en pacientes con artritis reumatoide tratados con anti-factor de necrosis tumoral alfa
This article reviews the papers published on the factors related to the development of adverse effects in rheumatoid arthritis patients treated with anti-tumor necrosis factor-α drugs.
The adverse effects studied were: infectious disease, cardiovascular complications, tumor development and mortality risk.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
